BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 24376268)

  • 1. Possible pitfalls investigating cell death responses in genetically engineered mouse models and derived cell lines.
    Manzl C; Baumgartner F; Peintner L; Schuler F; Villunger A
    Methods; 2013 Jun; 61(2):130-7. PubMed ID: 23454286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Author Correction: Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice.
    Wang L; Aschenbrenner D; Zeng Z; Cao X; Mayr D; Mehta M; Capitani M; Warner N; Pan J; Wang L; Li Q; Zuo T; Cohen-Kedar S; Lu J; Ardy RC; Mulder DJ; Dissanayake D; Peng K; Huang Z; Li X; Wang Y; Wang X; Li S; Bullers S; Gammage AN; Warnatz K; Schiefer AI; Krivan G; Goda V; Kahr WHA; Lemaire M; ; Lu CY; Siddiqui I; Surette MG; Kotlarz D; Engelhardt KR; Griffin HR; Rottapel R; Decaluwe H; Laxer RM; Proietti M; Hambleton S; Elcombe S; Guo CH; Grimbacher B; Dotan I; Ng SC; Freeman SA; Snapper SB; Klein C; Boztug K; Huang Y; Li D; Uhlig HH; Muise AM
    Nat Genet; 2022 Feb; 54(2):213. PubMed ID: 34987219
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetics of follicular lymphoma transformation.
    Pasqualucci L; Khiabanian H; Fangazio M; Vasishtha M; Messina M; Holmes AB; Ouillette P; Trifonov V; Rossi D; Tabbò F; Ponzoni M; Chadburn A; Murty VV; Bhagat G; Gaidano G; Inghirami G; Malek SN; Rabadan R; Dalla-Favera R
    Cell Rep; 2014 Jan; 6(1):130-40. PubMed ID: 24388756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia.
    Chen Z; Shojaee S; Buchner M; Geng H; Lee JW; Klemm L; Titz B; Graeber TG; Park E; Tan YX; Satterthwaite A; Paietta E; Hunger SP; Willman CL; Melnick A; Loh ML; Jung JU; Coligan JE; Bolland S; Mak TW; Limnander A; Jumaa H; Reth M; Weiss A; Lowell CA; Müschen M
    Nature; 2015 May; 521(7552):357-61. PubMed ID: 25799995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of STAT5 blocks TEL-SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in mice.
    Sprissler C; Belenki D; Maurer H; Aumann K; Pfeifer D; Klein C; Müller TA; Kissel S; Hülsdünker J; Alexandrovski J; Brummer T; Jumaa H; Duyster J; Dierks C
    Blood Cancer J; 2014 Aug; 4(8):e240. PubMed ID: 25148222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SYK is a critical regulator of FLT3 in acute myeloid leukemia.
    Puissant A; Fenouille N; Alexe G; Pikman Y; Bassil CF; Mehta S; Du J; Kazi JU; Luciano F; Rönnstrand L; Kung AL; Aster JC; Galinsky I; Stone RM; DeAngelo DJ; Hemann MT; Stegmaier K
    Cancer Cell; 2014 Feb; 25(2):226-42. PubMed ID: 24525236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer.
    Zhao EY; Shen Y; Pleasance E; Kasaian K; Leelakumari S; Jones M; Bose P; Ch'ng C; Reisle C; Eirew P; Corbett R; Mungall KL; Thiessen N; Ma Y; Schein JE; Mungall AJ; Zhao Y; Moore RA; Den Brok W; Wilson S; Villa D; Shenkier T; Lohrisch C; Chia S; Yip S; Gelmon K; Lim H; Renouf D; Sun S; Schrader KA; Young S; Bosdet I; Karsan A; Laskin J; Marra MA; Jones SJM
    Clin Cancer Res; 2017 Dec; 23(24):7521-7530. PubMed ID: 29246904
    [No Abstract]   [Full Text] [Related]  

  • 8. T and NK cell lymphoma cell lines do not rely on ZAP-70 for survival.
    de Mel S; Mustafa N; Selvarajan V; Azaman MI; Jaynes PW; Venguidessane S; Phuong HM; Alnaseri ZT; Phyu T; Girard LP; Chng WJ; Wardyn J; Li Y; An O; Yang H; Ng SB; Jeyasekharan AD
    PLoS One; 2022; 17(1):e0261469. PubMed ID: 35077445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host T Cell Dedifferentiation Effects Drive HIV-1 Latency Stability.
    Dalecki AG; Greer BD; Duverger A; Strange EL; Carlin E; Wagner F; Shi B; Lowman KE; Perez M; Tidwell C; Kaczmarek Michaels K; Giattina S; Bossmann SH; Henderson AJ; Hu H; Kutsch O
    J Virol; 2022 Mar; 96(5):e0197421. PubMed ID: 35019721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Determinants of B Cell Receptor Signaling as Prototype Molecular Biomarkers of Leukemia.
    Nicolò A; Linder AT; Jumaa H; Maity PC
    Front Oncol; 2021; 11():771669. PubMed ID: 34993136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral T cell lymphomas: from the bench to the clinic.
    Fiore D; Cappelli LV; Broccoli A; Zinzani PL; Chan WC; Inghirami G
    Nat Rev Cancer; 2020 Jun; 20(6):323-342. PubMed ID: 32249838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome profiling revealed the activation of IL2RG/JAK3/STAT5 in peripheral T‑cell lymphoma expressing the ITK‑SYK fusion gene.
    Zhang LL; Pan HX; Wang YX; Guo T; Liu L
    Int J Oncol; 2019 Nov; 55(5):1077-1089. PubMed ID: 31545408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into Blimp-1 in T lymphocytes: a divergent regulator of cell destiny and effector function.
    Fu SH; Yeh LT; Chu CC; Yen BL; Sytwu HK
    J Biomed Sci; 2017 Jul; 24(1):49. PubMed ID: 28732506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the Use of Murine Models in Leukemia and Lymphoma Research.
    Kohnken R; Porcu P; Mishra A
    Front Oncol; 2017; 7():22. PubMed ID: 28265553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Pathogenesis of Peripheral T Cell Lymphoma.
    Sakata-Yanagimoto M; Chiba S
    Curr Hematol Malig Rep; 2015 Dec; 10(4):429-37. PubMed ID: 26431836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A three-signal model of T-cell lymphoma pathogenesis.
    Wilcox RA
    Am J Hematol; 2016 Jan; 91(1):113-22. PubMed ID: 26408334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.
    Krisenko MO; Geahlen RL
    Biochim Biophys Acta; 2015 Jan; 1853(1):254-63. PubMed ID: 25447675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premature terminal differentiation protects from deregulated lymphocyte activation by ITK-Syk.
    Bach MP; Hug E; Werner M; Holch J; Sprissler C; Pechloff K; Zirlik K; Zeiser R; Dierks C; Ruland J; Jumaa H
    J Immunol; 2014 Feb; 192(3):1024-33. PubMed ID: 24376268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease.
    Dierks C; Adrian F; Fisch P; Ma H; Maurer H; Herchenbach D; Forster CU; Sprissler C; Liu G; Rottmann S; Guo GR; Katja Z; Veelken H; Warmuth M
    Cancer Res; 2010 Aug; 70(15):6193-204. PubMed ID: 20670954
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.